Concepedia

Deepika Sharma Das

DS

Statistics

Publications

17

Citations

1K

H-Index

15

Active since

2012

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Texas A&M University

National Institute of Immunology

Brigham and Women's Hospital

Deepika Sharma Das is an author at Dana-Farber Cancer Institute specializing in multiple myeloma, medicine, and oncology.

ORCID

Publications per year

2012–2019

17

Publications

17

Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7

Ilaria Lamberto, Xiaoxi Liu, Hyuk‐Soo Seo et al. · Cell chemical biology · 2017 · 188 citations · Full text

, , +14

Blockade of deubiquitylating enzyme Rpn11 triggers apoptosis in multiple myeloma cells and overcomes bortezomib resistance

Yan Song, S Li, Arjun Ray et al. · Oncogene · 2017 · 108 citations

, , +14

Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells

Deepika Sharma Das, Abhishek Das, Arghya Ray et al. · Clinical Cancer Research · 2017 · 101 citations · Full text

, , +15

A novel hypoxia-selective epigenetic agent RRx-001 triggers apoptosis and overcomes drug resistance in multiple myeloma cells

Deepika Sharma Das, Arghya Ray, Abhishek Das et al. · Leukemia · 2016 · 84 citations · Full text

, , +14

Targeting proteasome ubiquitin receptor Rpn13 in multiple myeloma

Yan Song, Arghya Ray, S Li et al. · Leukemia · 2016 · 78 citations · Full text

, , +14

1–5 of 17